Global Acne Drugs Market Insights and Trends, Positive and Negative Factors, Potential Markets, Key Developments, Segments, and Forecast 2023 – 2033
Global Acne Drugs Market was valued at USD 11200 Million in 2023 and is reach to USD 6000 Million by 2033 at a CAGR of 6.44%
“Global Acne Drugs Market” report 2023 focuses on the causes and symptoms of acne, the target consumers and benefits of acne drugs, market drivers, trends, etc. The global acne drugs market report has been segmented on the basis of acne type, therapeutic class, mode of administration, and region.
The global acne drug market is a segment of the pharmaceutical industry that focuses on the development and sales of medications used to treat acne. The market is driven by factors such as the increasing prevalence of acne, rising awareness about skincare, and growing disposable income. The market is segmented by drug class, such as topical retinoids, topical antibiotics, oral antibiotics, and hormonal therapy. Key players in the market include Johnson & Johnson, GlaxoSmithKline, Allergan, Galderma, and Bayer. The market is expected to grow at a steady rate in the forecast period due to the increasing prevalence of acne and growing awareness about skin care.
Acne is a major skin infection that is mostly contracted by teenagers or younger women due to a certain imbalance in the body. Some other causes for acne to occur on the face include oily skin, dead skin cells, dust, bacteria, hormonal imbalance, stress, inadequate consumption of water, higher consumption of sugars, salts, or carbohydrates, etc. Acne treatment can be classified into mainly six types including whiteheads (small and under stay-under skin), blackheads (black and visible on skin), papules (small and pink crashes), pustules (red pimples with pus and quite painful), nodules (large and painful pimples implanted in the deep skin), and cysts (painful and occur with pus and cause marks), among others.
Market Dynamics: Driving & Hampering Factors, and Growth Opportunities
The increasing prevalence of acne, especially in teenagers and young women, coupled with rising consciousness about looks and appearance among women are among some of the major factors driving the growth of the global acne drugs market to a significant extent. In addition, rising depression rates and low self-esteem because of acne, along with need for drugs or medication to get rid of acne and resulting marks in order to build and maintain confidence in self are among other major factors driving demand for acne drugs and supporting the growth of the target market. Easy availability of acne drugs, increasing investments by major players for the development and production of drugs with enhanced effects, and pipeline products to be launched in the near future are key factors supporting growth of the global market.
Various companies are investing in research and development to develop more effective cures for acne, and the use of various natural herbs such as aloe vera, green tea, honey, jojoba oil, rosemary, etc. is increasing. Rising preference and demand for products with natural ingredients is an additional factor expected to drive growth of the global acne drugs market. Furthermore, shifting preference of consumers towards online purchasing, and rapidly rising number of manufacturers focusing on selling their products online in order to meet customers’ demand is a key trend observed in the target market, and this is anticipated to support market growth to a significant extent. Moreover, growing consciousness towards aesthetic appeal among male consumers, combined with easy availability of acne drugs that are suitable for men’s skin types is another factor fueling growth of the global acne drugs market.
However, availability of substitutes for acne drugs and treatments offered by local players, rising preference for homemade remedies, including preference for traditional remedies such as application of ingredients including lemon juice, papaya, green vegetables, apple cider vinegar, baking soda, honey, tea tree oil, ice cube, etc., and healthy eating habits are some of the major factors that could restrain growth of the global acne drugs market.
Analysis by Segment:
By Acne Type:
Among the acne type segments, the inflammatory acne-type segment is expected to account for dominant position in terms of revenue share in the target market. The comedonal acne type segment is anticipated to follow the inflammatory acne type segment in terms of revenue share, and is projected to register a moderate growth rate over the next 10 years.
By Therapeutic Class:
Among the therapeutic class segments, the Retinoid and antibiotics segments accounted for higher revenue shares that that of the other segments, and these two segments are expected to continue to contribute more than other segments in terms of revenue and volume in the global acne drugs market.
The market in North America market is expected to account for a significant share in terms of revenue in the target market, owing to growing demand from women for curing acne and the easy availability of acne drugs. The Asia Pacific market is expected to register the fastest growth rate in the target market in terms of revenue, owing to the high prevalence of diseases, disorders, and conditions such as anxiety, abnormal hormone growth, high consumption of carbohydrates, and high consumption of fatty food and junk food.
Global Acne Drugs Market Segmentation:
Global Market Segmentation, by Acne Type:
Global Market Segmentation, by Therapeutic Class:
- Hormonal Agent
Global Market Segmentation, by Mode of Administration:
Global Market Segmentation, by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size USD 11200 Million Growth Rate 6.44% Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2023-2033 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Allergan Plc
- Nestlé S.A. (Galderma S.A.)
- Johnson & Johnson
- Mayne Pharma Group Limited
- Mylan N.V.
- Pfizer Inc.
- GlaxoSmithKline Plc (Stiefel Laboratories, Inc.)
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
- Valeant Pharmaceuticals International, Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!